drugset
Drugs / LP GMNL-133
last change Jun 2014 re-read 3 minutes ago

LP GMNL-133

also known as Lactobacillus paracasei GMNL-133
Developed for
asthma · atopic eczema
Investigated by
GenMont Biotech Incorporation · National Science and Technology Council, Taiwan

Trials 1

today NCT01635738 · not/applicable
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01635738 Dec 2011 → Jun 2014 asthma, atopic eczema GenMont Biotech Incorporation Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LP GMNL-133 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01635738 ↗
Known as Lactobacillus paracasei GMNL-133 “Lactobacillus paracasei GMNL-133(LP)” NCT01635738 ↗
Route Oral “One capsule with 2x10\^9 (cfu) LP GMNL-133, once daily, PO” NCT01635738 ↗